Almost three-fourths of patients with biochemically recurrent prostate cancer remained metastasis free at 5 years following ...
A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now ...
New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...
New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...
A doctor in El Paso performed the region’s first minimally invasive procedure using a new device designed to help patients ...
Prostate cancer is the most common cancer diagnosis in men, accounting for 30% of male cancers in 2025, and is the second most common cancer in men behind skin cancer, according to the American Cancer ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
Lawmakers want to require informed patient consent for some medical procedures. A bill moving through the legislature would ...
The results are in from those medical tests you took last week, and they might as well be written in Sanskrit. You could ...
Jerry McCormick, a 57-year-old San Diego journalist, was diagnosed with prostate cancer after a routine check-up and has since been documenting his experience on Substack to educate others, while also ...
A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...
Mercy Medical Center is offering a new, noninvasive treatment option for men with localized prostate cancer using high-intensity focused ultrasound, also known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results